David Kaul
Humboldt University of Berlin
17 Papers
34 Citations
David Kaul is an academic researcher from Humboldt University of Berlin. The author has contributed to research in topics: Radiosurgery & Medicine. The author has an hindex of 2, co-authored 17 publications. Previous affiliations of David Kaul include German Cancer Research Center.
Chat about Author
Papers
High-grade astrocytoma with piloid features (HGAP): the Charité experience with a new central nervous system tumor entity.
Katja Bender,Eilís Perez,Mihaela Chirica,Mihaela Chirica,Julia Onken,Johannes Kahn,Winfried Brenner,Winfried Brenner,Felix Ehret,Philipp Euskirchen,Philipp Euskirchen,Arend Koch,David Capper,David Capper,David Kaul,David Kaul +15 more
TL;DR: The first single-center experience with high-grade astrocytoma with piloid features (HGAP) was presented in this paper, where six HGAP were identified during 2017 and 2020.
Image-Guided Robotic Radiosurgery for Treatment of Recurrent Grade II and III Meningiomas. A Single-Center Study.
Güliz Acker,Franziska Meinert,Alfredo Conti,Alfredo Conti,Markus Kufeld,Claudius Jelgersma,Phuong Thuy Anh Nguyen,Anne Kluge,Mathias Lukas,Franziska Loebel,Diana Pasemann,David Kaul,Volker Budach,Peter Vajkoczy,Carolin Senger +14 more
TL;DR: Although the real boundaries of efficacy of SRS have to be further evaluated in a prospective trial, it appears that aggressive treatment by high-dose single or multisession SRS of recurring malignant meningiomas provides satisfactory local control rates.
18
Significance of tumor mutation burden and immune infiltration in thymic epithelial tumors.
Zi-Ming Wang,Zi-Ming Wang,Qi-Rong Xu,David Kaul,Mahmoud Ismail,Mahmoud Ismail,Harun Badakhshi,Harun Badakhshi +7 more
TL;DR: In this paper, the CIBERSORT algorithm was used to evaluate immune cell infiltration in Thymic epithelial tumors (TETs) and its relationship with TMB.
12
Integration of radiation oncology teaching in medical studies by German medical faculties due to the new licensing regulations : An overview and recommendations of the consortium academic radiation oncology of the German Society for Radiation Oncology (DEGRO).
Hendrik Dapper,Claus Belka,F. Bock,Volker Budach,Wilfried Budach,Hans Christiansen,Jürgen Debus,Luitpold Distel,J. Dunst,Franziska Eckert,Hans-Theodor Eich,Wolfgang Eicheler,Rita Engenhart-Cabillic,Rainer Fietkau,D.F. Fleischmann,B. Frerker,Frank A. Giordano,Anca-L. Grosu,Klaus Herfarth,Guido Hildebrandt,David Kaul,Oliver Kölbl,Mechthild Krause,David Krug,Daniel Martin,Christiane Matuschek,Daniel Medenwald,Nils H. Nicolay,Marcus Niewald,Michael Oertel,Cordula Petersen,Fabian Pohl,Annette Raabe,Claus Rödel,Christian Rübe,Claudia Schmalz,Leonard Christopher Schmeel,Diana Steinmann,G. Stüben,Reinhard Thamm,Dirk Vordermark,Hilke Vorwerk,Thomas Wiegel,Daniel Zips,Stephanie E. Combs +44 more
TL;DR: In this paper, the authors present a survey on the current state of radiation therapy teaching at university hospitals in Germany as well as the contents of the National Competence Based Learning Objectives Catalogue for Medicine 2.0 (nationaler Kompetenzbasierter Lernzielkatalog Medizin 2. 0, NKLM) and the closely related Subject Catalogue (Gegenstandskatalog, GK) of the Institute for Medical and Pharmaceutical Examination Questions (Institut fur MEDizinische und Pharmazeutische Prufungsfr
11
Radiotherapeutic treatment options for oligotopic malignant liver lesions.
Peter Wust,Marcus Beck,Robert Dabrowski,Oliver Neumann,Sebastian Zschaeck,David Kaul,Dominik Paul Modest,Carmen Stromberger,Bernhard Gebauer,Pirus Ghadjar +9 more
TL;DR: In this article, the authors compared the performance of HDR-brachytherapy, Cyberknife, volume-modulated-arc therapy (VMAT), and Tomotherapy for intrahepatic malignant liver lesions.